D. A. Berry

Statistical Methodology in the Pharmaceutical Sciences (eBook, PDF)

• Format: PDF

Produktbeschreibung

A state-of-the-art handbook of statistical analysis for use in the pharmaceutical industry. Areas covered in this reference/text include: bioavailability, repeated-measures designs, dose-response, population models, multicenter trials, handling dropouts, survival analysis, robust data analysis, cate

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Taylor & Francis eBooks
• Seitenzahl: 592
• Erscheinungstermin: 19. April 2016
• Englisch
• ISBN-13: 9781482276862
• Artikelnr.: 41069413

Autorenporträt

Berry, D. A.

Inhaltsangabe

Preface Contributors. 1. Basic Principles in Designing and Analyzing
Clinical Studies. 2. Bioavailability: Designs and Analysis. 3. Analysis of
Repeated-Measures Designs. 4. Dose-Response: Relating Doses and Plasma
Levels to Efficacy and Adverse Experiences. 5. Population Models. 6. Linear
and Nonlinear Regression. 7. Design and Analysis of Multicenter Trials. 8.
Crossover Versus Parallel Designs. 9. Handling Dropouts and Related Issues.
10. Group Sequential Methods in Clinical Trials. 11. Survival Analysis. 12.
Robust Data Analysis. 13. Categorical Data Analysis. 14. Causality
Assessment for Adverse Drug Reactions. 15. Bayesian Metaanalysis. 16.
Inferential Problems in Postmarketing Surveillance. Index

---

Preface Contributors. 1. Basic Principles in Designing and Analyzing Clinical Studies. 2. Bioavailability: Designs and Analysis. 3. Analysis of Repeated-Measures Designs. 4. Dose-Response: Relating Doses and Plasma Levels to Efficacy and Adverse Experiences. 5. Population Models. 6. Linear and Nonlinear Regression. 7. Design and Analysis of Multicenter Trials. 8. Crossover Versus Parallel Designs. 9. Handling Dropouts and Related Issues. 10. Group Sequential Methods in Clinical Trials. 11. Survival Analysis. 12. Robust Data Analysis. 13. Categorical Data Analysis. 14. Causality Assessment for Adverse Drug Reactions. 15. Bayesian Metaanalysis. 16. Inferential Problems in Postmarketing Surveillance. Index